Development & Application of Innovative Models for Immunotherapy: Common Issues & Solutions in Non-Clinical Evaluation
Time: 2:30 pm
day: Conference Day 1
Details:
- Models for NK Cell-Based Immunotherapy: huHSC-NCG-hIL2 or huHSC-NCG-hIL15?
- Models for T Cell-Based Immunotherapy: huPBMC-NCG or huPBMC-NCG-MHCI/II-DKO?
- Resistance Models: PD-1 resistance and HER2 resistance models
